Susquehanna International Group’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-13,700
| Closed | -$266K | – | 10966 |
|
|
2018
Q1 | $266K | Sell |
13,700
-2,100
| -13% | -$41.2K | ﹤0.01% | 7826 |
|
|
2017
Q4 | $263K | Sell |
15,800
-13,500
| -46% | -$247K | ﹤0.01% | 7814 |
|
|
2017
Q3 | $595K | Sell |
29,300
-75,100
| -72% | -$1.44M | ﹤0.01% | 6217 |
|
|
2017
Q2 | $1.68M | Buy |
104,400
+36,700
| +54% | +$542K | ﹤0.01% | 4237 |
|
|
2017
Q1 | $856K | Buy |
67,700
+45,400
| +204% | +$548K | ﹤0.01% | 5463 |
|
|
2016
Q4 | $295K | Buy |
22,300
+2,400
| +12% | +$41K | ﹤0.01% | 8007 |
|
|
2016
Q3 | $472K | Buy |
+19,900
| New | +$535K | ﹤0.01% | 6158 |
|
|
2016
Q2 | – | Sell |
-13,900
| Closed | -$445K | – | 9798 |
|
|
2016
Q1 | $445K | Buy |
+13,900
| New | +$489K | ﹤0.01% | 6611 |
|
|
2015
Q3 | – | Sell |
-8,900
| Closed | -$409K | – | 10604 |
|
|
2015
Q2 | $409K | Buy |
8,900
+3,200
| +56% | +$152K | ﹤0.01% | 8011 |
|
|
2015
Q1 | $267K | Buy |
+5,700
| New | +$227K | ﹤0.01% | 8185 |
|
|
2014
Q4 | – | Sell |
-12,500
| Closed | -$296K | – | 10383 |
|
|
2014
Q3 | $296K | Sell |
12,500
-85,300
| -87% | -$2.19M | ﹤0.01% | 8051 |
|
|
2014
Q2 | $2.93M | Buy |
97,800
+2,500
| +3% | +$67.4K | ﹤0.01% | 3961 |
|
|
2014
Q1 | $2.52M | Buy |
+95,300
| New | +$2.38M | ﹤0.01% | 3935 |
|
|
2013
Q4 | – | Sell |
-46,300
| Closed | -$950K | – | 9551 |
|
|
2013
Q3 | $950K | Sell |
46,300
-35,400
| -43% | -$731K | ﹤0.01% | 5357 |
|
|
2013
Q2 | $1.63M | Buy |
+81,700
| New | +$1.45M | ﹤0.01% | 4228 |
|
Susquehanna International Group's IPXL Position: Q1 2018 in Review
Susquehanna International Group sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 27,834 shares — an estimated $546K sold.
Susquehanna International Group first reported a position in IPXL in Q2 2013 and held it in 15 quarters. The position peaked at $5.04M in Q1 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.
- Susquehanna International Group reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
- Susquehanna International Group sold 27,834 Impax Laboratories, Inc. shares in Q1 2018, an estimated $546K.
- Susquehanna International Group first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 15 quarters.
- Susquehanna International Group's Impax Laboratories, Inc. position peaked at $5.04M in Q1 2015.
- 188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.
Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.